What are the major opportunities in the Xgeva market? What are the strategies for the Xgeva market?

For detailed insights on the major opportunities and strategies in the Xgeva market, Read More

How does the Xgeva market relate to the overall economy and other similar markets?

For detailed insights on Xgeva's relation to the overall economy and other similar markets, Read More

What are the latest mergers and acquisitions in the Xgeva industry?

For detailed insights on the mergers and acquisitions in the Xgeva industry, Read More

What are the key dynamics influencing the Xgeva market growth? SWOT analysis of the Xgeva market.

For detailed insights on the key dynamics influencing the Xgeva market growth and SWOT analysis of the Xgeva industry, Read More

Report Price : $4490.00

Pages :

Format : PDF

Published : December 2025

Delivery Time : 2-3 Business Days

Purchase This Report Download Sample PDF

Purchase This Report

Xgeva Global Market Report 2025

Name: Xgeva Global Market Report 2025
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

By Formulation (60 Mg Injection, 120 Mg Injection), By Indication (Bone Metastases, Giant Cell Tumor of Bone (GCTB), Hypercalcemia of Malignancy), By End User (Hospitals, Homecare, Specialty Clinics, Ambulatory Surgical Centers), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies)

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

What Is Covered Under Xgeva Market?

Xgeva (denosumab) refers to a monoclonal antibody used in the prevention of skeletal-related events (SREs) in patients with bone metastases from solid tumors and in the treatment of giant cell tumors of bone and osteoporosis in high-risk patients. It is utilized through subcutaneous injections administered by a healthcare professional.

The main types of formulations in xgeva include 60 mg injection and 120 mg injection. Xgeva formulation with a dosage of 60 mg, typically administered as a single injection to address specific patient needs based on prescribed treatment regimens, focusing on conditions requiring lower dosages. The indications include bone metastases, giant cell tumor of bone (GCTB), and hypercalcemia of malignancy for end users such as hospitals, Homecare, specialty clinics, and ambulatory surgical centers. The distribution channels include hospitals, retail pharmacies, and online pharmacies.

Xgeva Market Size and growth rate 2025 to 2029: Graph

What Is The Xgeva Market Size 2025 And Growth Rate?

The xgeva market size has XX (HCAGR) in recent years. It will grow from $XX million in 2024 to $XX million in 2025 at a compound annual growth rate (CAGR) of XX%. The growth in the historic period can be attributed to increasing cancer prevalence, rising awareness of bone metastases, growing geriatric population, increasing healthcare expenditure, improved regulatory approvals, growing investment in oncology research, and rising prevalence of skeletal-related events.

What Is The Xgeva Market Growth Forecast?

The xgeva market size is expected to see XX (FCAGR) in the next few years. It will grow to $XX million in 2029 at a compound annual growth rate (CAGR) of XX%. The growth in the forecast period can be attributed to increasing incidence of bone-related metastases in cancer patients, growing adoption of Xgeva in cancer treatment regimens, rising awareness of the drug's benefits, and growing aging population. Major trends in the forecast period include expanding indications for bone-related cancers, innovations in treatment delivery methods, and advancements in personalized medicine.

Book your 30 minutes free consultation with our research experts

How Is The Xgeva Market Segmented?

The xgeva market covered in this report is segmented –

1) By Formulation: 60 Mg Injection; 120 Mg Injection

2) By Indication: Bone Metastases; Giant Cell Tumor of Bone (GCTB); Hypercalcemia of Malignancy

3) By End User: Hospitals; Homecare; Specialty Clinics; Ambulatory Surgical Centers

4) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies

What Is Driving The Xgeva Market? Increasing Prevalence Of Bone Metastasis Boosts Market

The increasing prevalence of bone metastasis is propelling the growth of the xgeva market. Bone metastasis refers to the spread of cancer cells from their original site to the bones, often causing pain, fractures, and a range of other complications. The increase in prevalence of bone metastasis is due to the rising global incidence of cancers, particularly breast, prostate, and lung cancers, which are more likely to metastasize to the bones. As the prevalence of bone metastasis increases, the demand for effective treatments to manage bone-related complications also grows, positioning xgeva as a critical therapeutic option for preventing fractures and improving patient outcomes in individuals affected by metastatic bone disease. For instance, in January 2024, according to the American Cancer Society, a US-based nonprofit cancer advocacy organization, the number of bone and joint metastatic cancer cases increased to 3,970 compared to 3,910 in 2022, reflecting a growth of 1.5%. Therefore, the increasing prevalence of bone metastasis is expected to drive the growth of the xgeva market.

Who Are The Major Players In The Global Xgeva Market?

Major companies operating in the xgeva market are Amgen Inc.

What Are The Key Trends Of The Global Xgeva Market? New Formulation Enhances Patient Access And Convenience

The key trend in the xgeva market is focusing on expanding their product offerings, enhancing formulations such as prefilled syringes, and improving patient access to treatment. A prefilled syringe refers to a single-dose, ready-to-use syringe preloaded with medication, designed to simplify administration, improve dosing accuracy, and enhance patient convenience. For instance, in March 2024, the Medicines and Healthcare Products Regulatory Agency, a UK-based government agency responsible for regulating medicines, approved a new high-concentration formulation of Amgen's Xgeva (denosumab) as a 120 mg solution for injection in a prefilled syringe. This approval, granted under the new International Recognition Procedure (IRP), enables UK patients to access a more convenient and streamlined treatment option. Furthermore, this move enhances patient experience by simplifying the administration process, reducing the volume of liquid injected, and lowering the risk of dosing errors.

Need data on a specific region in this market?

Request Regional Data

What Are Latest Mergers And Acquisitions In The Xgeva Market? Alvotech And Dr. Reddy’s Collaboration Accelerates Commercialization Of AVT03 (Denosumab)

In May 2024, Alvotech, a Luxembourg-based company specializing in the development and manufacture of biosimilar medicines, collaborated with Dr. Reddy’s Laboratories SA. to accelerate the commercialization of AVT03 (denosumab), a biosimilar candidate to Xgeva, by leveraging Dr. Reddy’s established presence in the U.S., Europe, and the UK, ensuring broader access to affordable treatment options for patients with conditions such as osteoporosis and bone-related complications from cancer. Dr. Reddy’s Laboratories SA is an India-based global pharmaceutical company involved in the development and manufacture of medicines.

Regional Analysis For The Global Xgeva Market

North America was the largest region in the xgeva market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the xgeva market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the xgeva market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada.

What Defines the Xgeva Market?

The xgeva market consists of sales of prefilled syringes and vials. Values in this market are ‘factory gate’ values, representing the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Xgeva Industry?

The xgeva market research report is one of a series of new reports from The Business Research Company that provides xgeva market statistics, including xgeva industry global market size, regional shares, competitors with a xgeva market share, detailed xgeva market segments, market trends and opportunities, and any further data you may need to thrive in the xgeva industry. This xgeva market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Xgeva Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2025	Included ?
Revenue Forecast In 2034	Included ?
Growth Rate	Included ?
Base Year For Estimation	2024
Actual Estimates/Historical Data	2019-2024
Forecast Period	2025 - 2029 - 2034
Market Representation	Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered	The xgeva market covered in this report is segmented – 1) By Formulation: 60 Mg Injection; 120 Mg Injection 2) By Indication: Bone Metastases; Giant Cell Tumor of Bone (GCTB); Hypercalcemia of Malignancy 3) By End User: Hospitals; Homecare; Specialty Clinics; Ambulatory Surgical Centers 4) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled	Amgen Inc.
Customization Scope	Request for Sample
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

2. Xgeva Market Characteristics

3. Xgeva Market Biologic Drug Characteristics

3.1. Molecule Type

3.2. Route Of Administration (ROA)

3.3. Mechanism Of Action (MOA)

3.4. Safety And Efficacy

4. Xgeva Market Trends And Strategies

5. Xgeva Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

6. Global Xgeva Growth Analysis And Strategic Analysis Framework

6.1. Global Xgeva PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

6.2. Analysis Of End Use Industries

6.3. Global Xgeva Market Growth Rate Analysis

6.4. Global Xgeva Historic Market Size and Growth, 2019 - 2024, Value ($ Million)

6.5. Global Xgeva Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Million)

6.6. Global Xgeva Total Addressable Market (TAM)

7. Global Xgeva Pricing Analysis & Forecasts

8. Xgeva Market Segmentation

8.1. Global Xgeva Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

60 Mg Injection

120 Mg Injection

8.2. Global Xgeva Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Bone Metastases

Giant Cell Tumor of Bone (GCTB)

Hypercalcemia of Malignancy

8.3. Global Xgeva Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Hospitals

Homecare

Specialty Clinics

Ambulatory Surgical Centers

8.4. Global Xgeva Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Hospital Pharmacies

Retail Pharmacies

Online Pharmacies

9. Global Xgeva Epidemiology Of Clinical Indications

9.1. Drug Side Effects

9.2. Incidence And Prevalence of Clinical Indications

10. Xgeva Market Regional And Country Analysis

10.1. Global Xgeva Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

10.2. Global Xgeva Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

11. Asia-Pacific Xgeva Market

11.1. Asia-Pacific Xgeva Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Xgeva Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

11.3. Asia-Pacific Xgeva Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

11.4. Asia-Pacific Xgeva Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

12. China Xgeva Market

12.1. China Xgeva Market Overview

12.2. China Xgeva Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Million

12.3. China Xgeva Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Million

12.4. China Xgeva Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Million

13. India Xgeva Market

13.1. India Xgeva Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

13.2. India Xgeva Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

13.3. India Xgeva Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

14. Japan Xgeva Market

14.1. Japan Xgeva Market Overview

14.2. Japan Xgeva Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

14.3. Japan Xgeva Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

14.4. Japan Xgeva Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

15. Australia Xgeva Market

15.1. Australia Xgeva Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

15.2. Australia Xgeva Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

15.3. Australia Xgeva Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

16. South Korea Xgeva Market

16.1. South Korea Xgeva Market Overview

16.2. South Korea Xgeva Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

16.3. South Korea Xgeva Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

16.4. South Korea Xgeva Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

17. Western Europe Xgeva Market

17.1. Western Europe Xgeva Market Overview

17.2. Western Europe Xgeva Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

17.3. Western Europe Xgeva Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

17.4. Western Europe Xgeva Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

18. UK Xgeva Market

18.1. UK Xgeva Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

18.2. UK Xgeva Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

18.3. UK Xgeva Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

19. Germany Xgeva Market

19.1. Germany Xgeva Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

19.2. Germany Xgeva Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

19.3. Germany Xgeva Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

20. France Xgeva Market

20.1. France Xgeva Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

20.2. France Xgeva Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

20.3. France Xgeva Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

21. Eastern Europe Xgeva Market

21.1. Eastern Europe Xgeva Market Overview

21.2. Eastern Europe Xgeva Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

21.3. Eastern Europe Xgeva Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

21.4. Eastern Europe Xgeva Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

22. North America Xgeva Market

22.1. North America Xgeva Market Overview

22.2. North America Xgeva Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

22.3. North America Xgeva Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

22.4. North America Xgeva Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

23. USA Xgeva Market

23.1. USA Xgeva Market Overview

23.2. USA Xgeva Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

23.3. USA Xgeva Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

23.4. USA Xgeva Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

24. Canada Xgeva Market

24.1. Canada Xgeva Market Overview

24.2. Canada Xgeva Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

24.3. Canada Xgeva Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

24.4. Canada Xgeva Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

25. South America Xgeva Market

25.1. South America Xgeva Market Overview

25.2. South America Xgeva Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

25.3. South America Xgeva Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

25.4. South America Xgeva Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

26. Middle East Xgeva Market

26.1. Middle East Xgeva Market Overview

26.2. Middle East Xgeva Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

26.3. Middle East Xgeva Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

26.4. Middle East Xgeva Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

27. Africa Xgeva Market

27.1. Africa Xgeva Market Overview

27.2. Africa Xgeva Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

27.3. Africa Xgeva Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

27.4. Africa Xgeva Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

28. Xgeva Market Competitive Landscape And Company Profiles

28.1. Xgeva Market Competitive Landscape

28.2. Xgeva Market Company Profiles

28.2.1. Amgen Inc. Overview, Products and Services, Strategy and Financial Analysis

29. Global Xgeva Market Pipeline Analysis

29.1. High Level Clinic Trail Information

30. Global Xgeva Market Competitive Benchmarking And Dashboard

31. Key Mergers And Acquisitions In The Xgeva Market

32. Recent Developments In The Xgeva Market

33. Xgeva Market High Potential Countries, Segments and Strategies

33.1 Xgeva Market In 2029 - Countries Offering Most New Opportunities

33.2 Xgeva Market In 2029 - Segments Offering Most New Opportunities

33.3 Xgeva Market In 2029 - Growth Strategies

33.3.1 Market Trend Based Strategies

33.3.2 Competitor Strategies

34. Appendix

34.1. Abbreviations

34.2. Currencies

34.3. Historic And Forecast Inflation Rates

34.4. Research Inquiries

34.5. The Business Research Company

34.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Historic Market Growth, 2019-2024, $ Million

Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Million

Table 3: Global Xgeva Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 4: Global Xgeva Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 5: Global Xgeva Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 6: Global Xgeva Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 7: Global Xgeva Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 8: Global Xgeva Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 9: Asia-Pacific, Xgeva Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 10: Asia-Pacific, Xgeva Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 11: Asia-Pacific, Xgeva Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 12: China, Xgeva Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 13: China, Xgeva Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 14: China, Xgeva Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 15: India, Xgeva Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 16: India, Xgeva Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 17: India, Xgeva Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 18: Japan, Xgeva Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 19: Japan, Xgeva Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 20: Japan, Xgeva Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 21: Australia, Xgeva Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 22: Australia, Xgeva Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 23: Australia, Xgeva Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 24: South Korea, Xgeva Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 25: South Korea, Xgeva Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 26: South Korea, Xgeva Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 27: Western Europe, Xgeva Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 28: Western Europe, Xgeva Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 29: Western Europe, Xgeva Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 30: UK, Xgeva Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 31: UK, Xgeva Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 32: UK, Xgeva Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 33: Germany, Xgeva Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 34: Germany, Xgeva Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 35: Germany, Xgeva Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 36: France, Xgeva Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 37: France, Xgeva Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 38: France, Xgeva Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 39: Eastern Europe, Xgeva Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 40: Eastern Europe, Xgeva Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 41: Eastern Europe, Xgeva Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 42: North America, Xgeva Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 43: North America, Xgeva Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 44: North America, Xgeva Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 45: USA, Xgeva Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 46: USA, Xgeva Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 47: USA, Xgeva Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 48: Canada, Xgeva Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 49: Canada, Xgeva Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 50: Canada, Xgeva Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 51: South America, Xgeva Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 52: South America, Xgeva Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 53: South America, Xgeva Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 54: Middle East, Xgeva Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 55: Middle East, Xgeva Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 56: Middle East, Xgeva Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 57: Africa, Xgeva Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 58: Africa, Xgeva Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 59: Africa, Xgeva Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 60: Amgen Inc. Financial Performance

List Of Figures

Figure 1: Global Historic Market Growth, 2019-2024, $ Million

Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Million

Figure 3: Global Xgeva Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 4: Global Xgeva Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 5: Global Xgeva Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 6: Global Xgeva Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 7: Global Xgeva Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 8: Global Xgeva Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 9: Asia-Pacific, Xgeva Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 10: Asia-Pacific, Xgeva Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 11: Asia-Pacific, Xgeva Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 12: China, Xgeva Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 13: China, Xgeva Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 14: China, Xgeva Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 15: India, Xgeva Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 16: India, Xgeva Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 17: India, Xgeva Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 18: Japan, Xgeva Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 19: Japan, Xgeva Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 20: Japan, Xgeva Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 21: Australia, Xgeva Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 22: Australia, Xgeva Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 23: Australia, Xgeva Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 24: South Korea, Xgeva Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 25: South Korea, Xgeva Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 26: South Korea, Xgeva Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 27: Western Europe, Xgeva Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 28: Western Europe, Xgeva Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 29: Western Europe, Xgeva Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 30: UK, Xgeva Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 31: UK, Xgeva Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 32: UK, Xgeva Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 33: Germany, Xgeva Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 34: Germany, Xgeva Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 35: Germany, Xgeva Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 36: France, Xgeva Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 37: France, Xgeva Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 38: France, Xgeva Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 39: Eastern Europe, Xgeva Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 40: Eastern Europe, Xgeva Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 41: Eastern Europe, Xgeva Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 42: North America, Xgeva Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 43: North America, Xgeva Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 44: North America, Xgeva Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 45: USA, Xgeva Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 46: USA, Xgeva Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 47: USA, Xgeva Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 48: Canada, Xgeva Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 49: Canada, Xgeva Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 50: Canada, Xgeva Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 51: South America, Xgeva Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 52: South America, Xgeva Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 53: South America, Xgeva Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 54: Middle East, Xgeva Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 55: Middle East, Xgeva Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 56: Middle East, Xgeva Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 57: Africa, Xgeva Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 58: Africa, Xgeva Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 59: Africa, Xgeva Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 60: Amgen Inc. Financial Performance

Advanced Therapy Medicinal Products Industry Poised for Rapid Expansion, Projected to Hit $104.43 Billion by 2029

Global Insights: Androgen Deprivation Therapy Market Expected to Surpass $10.49 Billion by 2029

2025 Anti-CD20 Monoclonal Antibodies Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

Future Projections: Anti-D Immunoglobulin Market to Reach $3.34 Billion by 2029 at 6.6% CAGR

A 2025 analysis offering size estimates, growth trends and technological innovations in the live cell imaging microscopes market.

A 2025 market overview covering growth forecasts, treatment landscape, and key stakeholders in the isovaleric acidemia treatment market.

A dynamic 2025 report outlining growth drivers, pipeline innovations, and key markets in liver cancer therapeutics.

A 2025 analysis tracking API pricing, competitive landscape, and growth strategies in the losartan potassium active pharmaceutical ingredient market.

Brain Tumor Drugs Market 2022 - By Drugs (Temozolomide, Bevacizumab), By End User (Hospital Pharmacies, Retail Pharmacies), And By Region, Opportunities And Strategies – Global Forecast To 2030...

View Report

Cancer Tumor Profiling Global Market Report 2025 – By Cancer Type (Lung Cancer, Breast Cancer, Colorectal Cancer, Prostate Cancer, Melanoma, Ovarian Cancer, Stomach Cancer, Pancreatic Cancer, Thyroid Cancer, Other Cancer...

View Report

Circulating Tumor Cells Global Market Report 2025 – By Product (Kits And Reagents, Blood Collection Tubes, Devices Or Systems), By Technology (CTC Enrichment, CTC Detection, CTC Analysis), By Specimen (Blood, Bone Marrow...

View Report

Tumor Necrosis Factor Inhibitor Drugs Global Market Report 2025 – By Product Type (Humira, Enbrel, Remicade, Simponi/Simponi Aria, Cimzia, Biosimilars ), By Route Of Administration (Subcutaneous Injection, Intravenous In...

View Report

Tumor Infiltrating Lymphocytes Global Market Report 2025 – By Anatomy (CD3, CD8, CD16, CD56, CD4, CD57, CD169, CD68, FOXP3), By Component (T-Cells, B-Cells, Natural Killer Cells), By Application (Melanoma, Cervical Cance...

View Report

Brain Tumor Drugs Global Market Report 2025 – By Drugs (Temozolomide, Bevacizumab, Other Drugs), By End User (Hospital Pharmacies, Retail Pharmacies/Drug Stores, Other End-Users) – Impact of Tariff and Trade War on Marke...

View Report

Tumor Ablation Therapy Devices Global Market Report 2025 – By Technology (Radiofrequency Ablation, Microwave Ablation, Cryoablation, Irreversible Electroporation Ablation, Other Technologies), By Treatment (Surgical, Lap...

View Report

Tumor Embolization Devices Global Market Report 2025 – By Type (Radioembolic Agents, Non-radioactive Embolic Agents), By Application (Cancer Tumors, Noncancerous Tumors), By End User (Hospitals, Cancer Treatment Centers,...

View Report

Frequently Asked Questions

What is the definition of the Xgeva market?

How will the Xgeva market drivers and restraints affect the market dynamics? What forces will shape the Xgeva industry going forward?

The Xgeva market major growth driver - Increasing Prevalence Of Bone Metastasis Boosts Market. For further insights on the Xgeva market, request a sample here

What is the forecast market size or the forecast market value of the Xgeva market?

The Xgeva market size has grown strongly in recent years. The xgeva market size has XX (HCAGR) in recent years. It will grow from $XX million in 2024 to $XX million in 2025 at a compound annual growth rate (CAGR) of XX%. The growth in the historic period can be attributed to increasing cancer prevalence, rising awareness of bone metastases, growing geriatric population, increasing healthcare expenditure, improved regulatory approvals, growing investment in oncology research, and rising prevalence of skeletal-related events. The xgeva market size is expected to see XX (FCAGR) in the next few years. It will grow to $XX million in 2029 at a compound annual growth rate (CAGR) of XX%. The growth in the forecast period can be attributed to increasing incidence of bone-related metastases in cancer patients, growing adoption of Xgeva in cancer treatment regimens, rising awareness of the drug's benefits, and growing aging population. Major trends in the forecast period include expanding indications for bone-related cancers, innovations in treatment delivery methods, and advancements in personalized medicine. For further insights on the Xgeva market, request a sample here

How is the Xgeva market segmented?

The xgeva market covered in this report is segmented –
1) By Formulation: 60 Mg Injection; 120 Mg Injection
2) By Indication: Bone Metastases; Giant Cell Tumor of Bone (GCTB); Hypercalcemia of Malignancy
3) By End User: Hospitals; Homecare; Specialty Clinics; Ambulatory Surgical Centers
4) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies For further insights on the Xgeva market, request a sample here

Which region has the largest share of the Xgeva market? What are the other regions covered in the report?

Who are the major players in the Xgeva market?

Major companies operating in the xgeva market are Amgen Inc. . For further insights on the Xgeva market, request a sample here.

What are the key trends in the Xgeva market?

Major trends in the Xgeva market include New Formulation Enhances Patient Access And Convenience. For further insights on the Xgeva market, request a sample here.

Book your 30 minutes free consultation with our research experts

Xgeva Global Market Report 2025

What Is Covered Under Xgeva Market?

What Is The Xgeva Market Size 2025 And Growth Rate?

What Is The Xgeva Market Growth Forecast?

How Is The Xgeva Market Segmented?

What Is Driving The Xgeva Market? Increasing Prevalence Of Bone Metastasis Boosts Market

Who Are The Major Players In The Global Xgeva Market?

What Are The Key Trends Of The Global Xgeva Market? New Formulation Enhances Patient Access And Convenience

What Are Latest Mergers And Acquisitions In The Xgeva Market? Alvotech And Dr. Reddy’s Collaboration Accelerates Commercialization Of AVT03 (Denosumab)

Regional Analysis For The Global Xgeva Market

What Defines the Xgeva Market?

How is Market Value Defined and Measured?

What is the Market Assessment and Strategic Outlook for the Xgeva Industry?

Xgeva Market Report Forecast Analysis

Table Of Contents

List Of Tables

List Of Figures

Frequently Asked Questions